{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:34:54Z","timestamp":1792449294886,"version":"4.5.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"INSPIRE Fellowship, Department of Science and Technology, Ministry of Science and Technology, Government of India","award":["IF180660"],"award-info":[{"award-number":["IF180660"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00204-025-04112-1","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:19:44Z","timestamp":1751437184000},"page":"3565-3578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A recent decade\u00a0update on combating\u00a0doxorubicin-induced toxicities"],"prefix":"10.1007","volume":"99","author":[{"given":"Sruthi","family":"Sritharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8998-8622","authenticated-orcid":false,"given":"Nageswaran","family":"Sivalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"4112_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuro.2022.07.005","volume":"92","author":"SA Abd El-Aal","year":"2022","unstructured":"Abd El-Aal SA, AbdElrahman M, Reda AM, Afify H, Ragab GM, El-Gazar AA, Ibrahim SSA (2022) Galangin mitigates DOX-induced cognitive impairment in rats: Implication of NOX-1\/Nrf-2\/HMGB1\/TLR4 and TNF-alpha\/MAPKs\/RIPK\/MLKL\/BDNF. Neurotoxicology 92:77\u201390","journal-title":"Neurotoxicology"},{"key":"4112_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112120","volume":"143","author":"EA Abdelghffar","year":"2021","unstructured":"Abdelghffar EA, Obaid WA, Elgamal AM, Daoud R, Sobeh M, El Raey MA (2021) Pea (Pisum sativum) peel extract attenuates DOX-induced oxidative myocardial injury. Biomed Pharmacother 143:112120","journal-title":"Biomed Pharmacother"},{"key":"4112_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.114119","volume":"182","author":"GA Abdel-Latif","year":"2023","unstructured":"Abdel-Latif GA, Al-Kashef AS, Nooman MU, Khattab AEA, Gebril SM, Elmongy NF, Abbas SS (2023) The mechanistic interplay between Nrf-2, NF-kappaB\/MAPK, caspase-dependent apoptosis, and autophagy in the hepatoprotective effects of Sophorolipids produced by microbial conversion of banana peels using Saccharomyces cerevisiae against doxorubicin-induced hepatotoxicity in rats. Food Chem Toxicol 182:114119","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"4112_CR4","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1021\/acs.molpharmaceut.0c00963","volume":"17","author":"CS Abdullah","year":"2020","unstructured":"Abdullah CS, Ray P, Alam S, Kale N, Aishwarya R, Morshed M, Quadir M (2020) Chemical architecture of block copolymers differentially abrogate cardiotoxicity and maintain the anticancer efficacy of doxorubicin. Mol Pharm 17(12):4676\u20134690","journal-title":"Mol Pharm"},{"issue":"1","key":"4112_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12906-017-2061-0","volume":"17","author":"T Afsar","year":"2017","unstructured":"Afsar T, Razak S, Batoo KM, Khan MR (2017) Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats. BMC Complement Altern Med 17(1):554","journal-title":"BMC Complement Altern Med"},{"issue":"9","key":"4112_CR6","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.sjbs.2020.07.011","volume":"27","author":"T Afsar","year":"2020","unstructured":"Afsar T, Razak S, Almajwal A, Al-Disi D (2020) Doxorubicin-induced alterations in kidney functioning, oxidative stress, DNA damage, and renal tissue morphology; Improvement by Acacia hydaspica tannin-rich ethyl acetate fraction. Saudi J Biol Sci 27(9):2251\u20132260","journal-title":"Saudi J Biol Sci"},{"issue":"2","key":"4112_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1200\/JCO.2002.20.2.485","volume":"20","author":"TA Ahles","year":"2002","unstructured":"Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Silberfarb PM (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20(2):485\u2013493","journal-title":"J Clin Oncol"},{"key":"4112_CR8","first-page":"6694340","volume":"2021","author":"AZ Ahmed","year":"2021","unstructured":"Ahmed AZ, Satyam SM, Shetty P, D\u2019Souza MR (2021a) Methyl gallate attenuates doxorubicin-induced cardiotoxicity in rats by suppressing oxidative stress. Scientifica (Cairo). 2021:6694340","journal-title":"Scientifica (Cairo)."},{"issue":"7","key":"4112_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12012-021-09644-3","volume":"21","author":"AZ Ahmed","year":"2021","unstructured":"Ahmed AZ, Mumbrekar KD, Satyam SM, Shetty P, D\u2019Souza MR, Singh VK (2021b) Chia seed oil ameliorates doxorubicin-induced cardiotoxicity in female wistar rats: an electrocardiographic, biochemical and histopathological approach. Cardiovasc Toxicol 21(7):533\u2013542","journal-title":"Cardiovasc Toxicol"},{"issue":"6","key":"4112_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/ahe.12735","volume":"50","author":"AT Akin","year":"2021","unstructured":"Akin AT, Ozturk E, Kaymak E, Karabulut D, Yakan B (2021) Therapeutic effects of thymoquinone in doxorubicin-induced hepatotoxicity via oxidative stress, inflammation and apoptosis. Anat Histol Embryol 50(6):908\u2013917","journal-title":"Anat Histol Embryol"},{"issue":"2","key":"4112_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/10520295.2019.1647457","volume":"95","author":"I Aktas","year":"2020","unstructured":"Aktas I, Ozmen O, Tutun H, Yalcin A, Turk A (2020) Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats. Biotech Histochem 95(2):121\u2013128","journal-title":"Biotech Histochem"},{"issue":"1","key":"4112_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/bcpt.13807","volume":"132","author":"RI Alagal","year":"2023","unstructured":"Alagal RI, AlFaris NA, Alshammari GM (2023) The protection afforded by Berberine against chemotherapy-mediated nephropathy in rats involves regulation of the antioxidant axis. Basic Clin Pharmacol Toxicol 132(1):98\u2013110","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"16","key":"4112_CR13","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3390\/ijms23168977","volume":"23","author":"C Algieri","year":"2022","unstructured":"Algieri C, Bernardini C, Oppedisano F, La Mantia D, Trombetti F, Palma E, Nesci S (2022) The impairment of cell metabolism by cardiovascular toxicity of doxorubicin is reversed by bergamot polyphenolic fraction treatment in endothelial cells. Int J Mol Sci 23(16):2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4112_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/15376516.2019.1600086","volume":"29","author":"AH Alhowail","year":"2019","unstructured":"Alhowail AH, Bloemer J, Majrashi M, Pinky PD, Bhattacharya S, Yongli Z, Suppiramaniam V (2019) Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation. Toxicol Mech Methods 29(6):457\u2013466","journal-title":"Toxicol Mech Methods"},{"issue":"8","key":"4112_CR15","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1016\/j.sjbs.2021.04.030","volume":"28","author":"N Ali","year":"2021","unstructured":"Ali N, AlAsmari AF, Imam F, Ahmed MZ, Alqahtani F, Alharbi M, Alanazi MM (2021) Protective effect of diosmin against doxorubicin-induced nephrotoxicity. Saudi J Biol Sci 28(8):4375\u20134383","journal-title":"Saudi J Biol Sci"},{"key":"4112_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jelectrocard.2019.02.009","volume":"55","author":"A Alihemmati","year":"2019","unstructured":"Alihemmati A, Ebadi F, Moghadaszadeh M, Asadi M, Zare P, Badalzadeh R (2019) Effects of high-intensity interval training on the expression of microRNA-499 and pro- and anti-apoptotic genes in doxorubicin-cardiotoxicity in rats. J Electrocardiol 55:9\u201315","journal-title":"J Electrocardiol"},{"key":"4112_CR17","doi-asserted-by":"publisher","first-page":"153473541986235","DOI":"10.1177\/1534735419862351","volume":"18","author":"S Al-Jaouni","year":"2019","unstructured":"Al-Jaouni S, Abdul-Hady S, El-Bassossy H, Salah N, Hagras M (2019) Ajwa nanopreparation prevents doxorubicin-associated cardiac dysfunction: effect on cardiac ischemia and antioxidant capacity. Integr Cancer Ther 18:1534735419862351","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"4112_CR18","first-page":"31","volume":"36","author":"ZH Al-Oanzi","year":"2023","unstructured":"Al-Oanzi ZH (2023) The effects of baicalein alone and in combination with losartan on DOX-induced nephrotoxicity in rats. Pak J Pharm Sci 36(1):31\u201338","journal-title":"Pak J Pharm Sci"},{"key":"4112_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112594","volume":"146","author":"WH Al-Qahtani","year":"2022","unstructured":"Al-Qahtani WH, Alshammari GM, Ajarem JS, Al-Zahrani AY, Alzuwaydi A, Eid R, Yahya MA (2022) Isoliquiritigenin prevents Doxorubicin-induced hepatic damage in rats by upregulating and activating SIRT1. Biomed Pharmacother 146:112594","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"4112_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/brainsci13060971","volume":"13","author":"RS Alsikhan","year":"2023","unstructured":"Alsikhan RS, Aldubayan MA, Almami IS, Alhowail AH (2023) Protective effect of galantamine against doxorubicin-induced neurotoxicity. Brain Sci 13(6):971","journal-title":"Brain Sci"},{"issue":"23","key":"4112_CR21","doi-asserted-by":"publisher","first-page":"12541","DOI":"10.3390\/ijms252312541","volume":"25","author":"AM Alsirhani","year":"2024","unstructured":"Alsirhani AM, Abu-Almakarem AS, Alwaili MA, Aljohani S, Alali I, AlRashidi AA, El-Said KS (2024) Syzygium aromaticum extract mitigates doxorubicin-induced hepatotoxicity in male rats. Int J Mol Sci 25(23):12541","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4112_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s12012-022-09748-4","volume":"22","author":"MT Alves","year":"2022","unstructured":"Alves MT, da Conceicao I, de Oliveira AN, Oliveira HHM, Soares CE, de Paula Sabino A, Gomes KB (2022) microRNA miR-133a as a biomarker for doxorubicin-induced cardiotoxicity in women with breast cancer: a signaling pathway investigation. Cardiovasc Toxicol 22(7):655\u2013662","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"4112_CR23","doi-asserted-by":"publisher","first-page":"11425","DOI":"10.1038\/s41598-020-68205-w","volume":"10","author":"F Andreata","year":"2020","unstructured":"Andreata F, Bonizzi A, Sevieri M, Truffi M, Monieri M, Sitia L, Mazzucchelli S (2020) Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model. Sci Rep 10(1):11425","journal-title":"Sci Rep"},{"issue":"35","key":"4112_CR24","doi-asserted-by":"publisher","first-page":"83421","DOI":"10.1007\/s11356-023-28146-z","volume":"30","author":"AH Atta","year":"2023","unstructured":"Atta AH, Atta SA, Khattab MS, El-Aziz THA, Mouneir SM, Ibrahim MA, Emam SR (2023) Ceratonia siliqua pods (Carob) methanol extract alleviates doxorubicin-induced nephrotoxicity via antioxidant, anti-inflammatory and anti-apoptotic pathways in rats. Environ Sci Pollut Res Int 30(35):83421\u201383438","journal-title":"Environ Sci Pollut Res Int"},{"issue":"2","key":"4112_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jtcme.2023.11.003","volume":"14","author":"RM Badi","year":"2024","unstructured":"Badi RM, Khaleel EF, Satti HH, Monir R (2024) Eriodictyol attenuates doxorubicin-induced nephropathy by activating the AMPK\/Nrf2 signalling pathway. J Tradit Complement Med 14(2):203\u2013214","journal-title":"J Tradit Complement Med"},{"issue":"12","key":"4112_CR26","doi-asserted-by":"publisher","first-page":"10222","DOI":"10.3390\/ijms241210222","volume":"24","author":"FP Boeno","year":"2023","unstructured":"Boeno FP, Patel J, Montalvo RN, Lapierre-Nguyen SS, Schreiber CM, Smuder AJ (2023) Effects of exercise preconditioning on doxorubicin-induced liver and kidney toxicity in male and female rats. Int J Mol Sci 24(12):10222","journal-title":"Int J Mol Sci"},{"key":"4112_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116794","volume":"482","author":"L Chen","year":"2024","unstructured":"Chen L, Sun X, Wang Z, Chen M, He Y, Zhang H, Zheng L (2024a) Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway. Toxicol Appl Pharmacol 482:116794","journal-title":"Toxicol Appl Pharmacol"},{"key":"4112_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153757","volume":"503","author":"M Chen","year":"2024","unstructured":"Chen M, Yi Y, Chen B, Zhang H, Dong M, Yuan L, Ma Z (2024b) Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice. Toxicology 503:153757","journal-title":"Toxicology"},{"issue":"3","key":"4112_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2005.10.027","volume":"101","author":"HH Chou","year":"2006","unstructured":"Chou HH, Wang KL, Chen CA, Wei LH, Lai CH, Yen MS (2006) Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up. Gynecol Oncol 101(3):423\u2013428","journal-title":"Gynecol Oncol"},{"issue":"4","key":"4112_CR30","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/jpm13040649","volume":"13","author":"B Cicek","year":"2023","unstructured":"Cicek B, Hacimuftuoglu A, Yeni Y, Danisman B, Ozkaraca M, Mokhtare B, Taghizadehghalehjoughi A (2023) Chlorogenic acid attenuates doxorubicin-induced oxidative stress and markers of apoptosis in cardiomyocytes via Nrf2\/HO-1 and dityrosine signaling. J Pers Med. 13(4):649","journal-title":"J Pers Med."},{"key":"4112_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jconrel.2015.06.040","volume":"213","author":"B Cote","year":"2015","unstructured":"Cote B, Carlson LJ, Rao DA, Alani AWG (2015) Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. J Control Release 213:128\u2013133","journal-title":"J Control Release"},{"key":"4112_CR32","doi-asserted-by":"publisher","first-page":"9481841","DOI":"10.1155\/2020\/9481841","volume":"2020","author":"Y Dai","year":"2020","unstructured":"Dai Y, Gao M, Li L, Mao Z, Xu L, Yin L, Peng J (2020) MicroRNA-874-3p aggravates doxorubicin-induced renal podocyte injury via targeting methionine sulfoxide reductase B3. Oxid Med Cell Longev 2020:9481841","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4112_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/2141-9248.126619","volume":"4","author":"G Damodar","year":"2014","unstructured":"Damodar G, Smitha T, Gopinath S, Vijayakumar S, Rao Y (2014) An evaluation of hepatotoxicity in breast cancer patients receiving injection Doxorubicin. Ann Med Health Sci Res 4(1):74\u201379","journal-title":"Ann Med Health Sci Res"},{"issue":"7","key":"4112_CR34","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/S0021-9258(17)35746-0","volume":"261","author":"KJ Davies","year":"1986","unstructured":"Davies KJ, Doroshow JH (1986) Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 261(7):3060\u20133067","journal-title":"J Biol Chem"},{"issue":"2","key":"4112_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0960327120950010","volume":"40","author":"F Demir","year":"2021","unstructured":"Demir F, Demir M, Aygun H (2021) Evaluation of the protective effect of paricalcitol and vitamin D(3) at doxorubicin nephrotoxicity in rats with (99m)Technetium-dimercaptosuccinic acid renal scintigraphy and biochemical methods. Hum Exp Toxicol 40(2):274\u2013283","journal-title":"Hum Exp Toxicol"},{"issue":"9","key":"4112_CR36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/jat.4309","volume":"42","author":"VG Desai","year":"2022","unstructured":"Desai VG, Vijay V, Lee T, Han T, Moland CL, Phanavanh B, Fuscoe JC (2022) MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicity. J Appl Toxicol 42(9):1477\u20131490","journal-title":"J Appl Toxicol"},{"issue":"4","key":"4112_CR37","volume":"7","author":"D Desai","year":"2024","unstructured":"Desai D, Majrashi M, Pathak S, Almaghrabi M, Liu K, Pondugula SR, Dhanasekaran M (2024) Evaluate the in vitro effect of anthracycline and alkylating cytophosphane chemotherapeutics on dopaminergic neurons. Cancer Rep (Hoboken) 7(4):e2074","journal-title":"Cancer Rep (Hoboken)"},{"issue":"12","key":"4112_CR38","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1073\/pnas.83.12.4514","volume":"83","author":"JH Doroshow","year":"1986","unstructured":"Doroshow JH (1986) Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc Natl Acad Sci U S A 83(12):4514\u20134518","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"4112_CR39","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1039\/D3NR06269D","volume":"16","author":"N Drinkovic","year":"2024","unstructured":"Drinkovic N, Beus M, Barbir R, Debeljak Z, Tariba Lovakovic B, Kalcec N, Vinkovic Vrcek I (2024) Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity. Nanoscale 16(19):9412\u20139425","journal-title":"Nanoscale"},{"key":"4112_CR40","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2021-0103","author":"AH El-Far","year":"2021","unstructured":"El-Far AH, Salaheldin TA, Godugu K, Darwish NH, Mousa SA (2021) Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. Nanomedicine (Lond). https:\/\/doi.org\/10.2217\/nnm-2021-0103","journal-title":"Nanomedicine (Lond)"},{"issue":"21","key":"4112_CR41","doi-asserted-by":"publisher","first-page":"15525","DOI":"10.3390\/ijms242115525","volume":"24","author":"KS El-Said","year":"2023","unstructured":"El-Said KS, Haidyrah AS, Mobasher MA, Khayyat AIA, Shakoori A, Al-Sowayan NS, Mariah RA (2023) Artemisia annua extract attenuate doxorubicin-induced hepatic injury via PI-3K\/Akt\/Nrf-2-mediated signaling pathway in rats. Int J Mol Sci 24(21):15525","journal-title":"Int J Mol Sci"},{"key":"4112_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03608-4","author":"WSM El-Sawy","year":"2024","unstructured":"El-Sawy WSM, Khalaf MM, El-Bahrawy AH, Messiha BAS, Hemeida RAM (2024) Oxyresveratrol and\/or Dapagliflozin Attenuate Doxorubicin-Induced Nephrotoxicity via Modulation of PPAR-gamma\/Nrf-2\/HO-1, NF-kappaB\/TNF-alpha\/Keap-1, and Bcl-2\/Caspase-3\/ATG-5 signaling pathways in rats. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03608-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4112_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cbi.2014.09.015","volume":"223","author":"NM Elsherbiny","year":"2014","unstructured":"Elsherbiny NM, El-Sherbiny M (2014) Thymoquinone attenuates Doxorubicin-induced nephrotoxicity in rats: Role of Nrf2 and NOX4. Chem Biol Interact 223:102\u2013108","journal-title":"Chem Biol Interact"},{"key":"4112_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.815916","volume":"9","author":"H Fa","year":"2022","unstructured":"Fa H, Xiao D, Chang W, Ding L, Yang L, Wang Y, Wang J (2022) MicroRNA-194-5p attenuates doxorubicin-induced cardiomyocyte apoptosis and endoplasmic reticulum stress by targeting P21-activated kinase 2. Front Cardiovasc Med 9:815916","journal-title":"Front Cardiovasc Med"},{"key":"4112_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111348","volume":"122","author":"Y Fan","year":"2024","unstructured":"Fan Y, Kang S, Shao T, Xu L, Chen J (2024) Activation of SIRT3 by Tanshinone IIA ameliorates renal fibrosis by suppressing the TGF-beta\/TSP-1 pathway and attenuating oxidative stress. Cell Signal 122:111348","journal-title":"Cell Signal"},{"issue":"12","key":"4112_CR46","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.bcp.2012.02.026","volume":"83","author":"RA Forrest","year":"2012","unstructured":"Forrest RA, Swift LP, Rephaeli A, Nudelman A, Kimura K, Phillips DR, Cutts SM (2012) Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation. Biochem Pharmacol 83(12):1602\u20131612","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4112_CR47","doi-asserted-by":"publisher","first-page":"7582730","DOI":"10.1155\/2018\/7582730","volume":"2018","author":"S Gorini","year":"2018","unstructured":"Gorini S, De Angelis A, Berrino L, Malara N, Rosano G, Ferraro E (2018) Chemotherapeutic drugs and mitochondrial dysfunction: focus on doxorubicin, trastuzumab, and sunitinib. Oxid Med Cell Longev 2018(1):7582730","journal-title":"Oxid Med Cell Longev"},{"key":"4112_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2016.01.002","volume":"32","author":"J Gu","year":"2016","unstructured":"Gu J, Hu W, Song ZP, Chen YG, Zhang DD, Wang CQ (2016) Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity. Int Immunopharmacol 32:1\u20137","journal-title":"Int Immunopharmacol"},{"key":"4112_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bcp.2018.02.025","volume":"150","author":"J Gu","year":"2018","unstructured":"Gu J, Fan YQ, Zhang HL, Pan JA, Yu JY, Zhang JF, Wang CQ (2018) Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion. Biochem Pharmacol 150:202\u2013213","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4112_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ymthe.2018.11.004","volume":"27","author":"SK Gupta","year":"2019","unstructured":"Gupta SK, Garg A, Avramopoulos P, Engelhardt S, Streckfuss-Bomeke K, Batkai S, Thum T (2019) miR-212\/132 cluster modulation prevents doxorubicin-mediated atrophy and cardiotoxicity. Mol Ther 27(1):17\u201328","journal-title":"Mol Ther"},{"issue":"4","key":"4112_CR51","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1161\/CIRCRESAHA.119.316061","volume":"127","author":"D Han","year":"2020","unstructured":"Han D, Wang Y, Wang Y, Dai X, Zhou T, Chen J, Cao F (2020) The tumor-suppressive human circular RNA CircITCH sponges miR-330-5p to ameliorate doxorubicin-induced cardiotoxicity through upregulating SIRT6, Survivin, and SERCA2a. Circ Res 127(4):e108\u2013e125","journal-title":"Circ Res"},{"issue":"4","key":"4112_CR52","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1124\/mol.114.093849","volume":"86","author":"AD Hanna","year":"2014","unstructured":"Hanna AD, Lam A, Tham S, Dulhunty AF, Beard NA (2014) Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A. Mol Pharmacol 86(4):438\u2013449","journal-title":"Mol Pharmacol"},{"issue":"Pt 1","key":"4112_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jcis.2025.01.006","volume":"684","author":"Y Hao","year":"2025","unstructured":"Hao Y, Li Y, Zang W, Sun Y, Li X, Li L, Sun B (2025) Self-assembled doxorubicin prodrug riding on the albumin express train enable tumor targeting and bio-activation. J Colloid Interface Sci 684(Pt 1):97\u2013108","journal-title":"J Colloid Interface Sci"},{"issue":"8","key":"4112_CR54","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1039\/C8FO00466H","volume":"9","author":"H He","year":"2018","unstructured":"He H, Luo Y, Qiao Y, Zhang Z, Yin D, Yao J, He M (2018) Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3gamma. Food Funct 9(8):4404\u20134418","journal-title":"Food Funct"},{"key":"4112_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.737826","volume":"8","author":"J Henderson","year":"2021","unstructured":"Henderson J, Dubey PK, Patil M, Singh S, Dubey S, Namakkal Soorappan R, Krishnamurthy P (2021) microRNA-377 signaling modulates anticancer drug-induced cardiotoxicity in mice. Front Cardiovasc Med 8:737826","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"4112_CR56","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1249\/MSS.0000000000001887","volume":"51","author":"JM Hinkley","year":"2019","unstructured":"Hinkley JM, Morton AB, Ichinoseki-Sekine N, Huertas AM, Smuder AJ (2019) Exercise training prevents doxorubicin-induced mitochondrial dysfunction of the liver. Med Sci Sports Exerc 51(6):1106\u20131115","journal-title":"Med Sci Sports Exerc"},{"issue":"7","key":"4112_CR57","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036593","volume":"103","author":"Z Hu","year":"2024","unstructured":"Hu Z (2024) Exploring the mechanism of curcumin in the treatment of doxorubicin-induced cardiotoxicity based on network pharmacology and molecular docking technology. Medicine (Baltimore) 103(7):e36593","journal-title":"Medicine (Baltimore)"},{"issue":"3\u20134","key":"4112_CR58","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000521220","volume":"107","author":"H Hu","year":"2022","unstructured":"Hu H, Xie C, Weng Z, Yu P, Wang Y, Shan L (2022) Dexrazoxane alleviated doxorubicin-induced nephropathy in rats. Pharmacology 107(3\u20134):206\u2013215","journal-title":"Pharmacology"},{"issue":"2","key":"4112_CR59","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15376516.2021.1965274","volume":"32","author":"J Huang","year":"2022","unstructured":"Huang J, Lei Y, Lei S, Gong X (2022) Cardioprotective effects of corilagin on doxorubicin induced cardiotoxicity via P13K\/Akt and NF-kappaB signaling pathways in a rat model. Toxicol Mech Methods 32(2):79\u201386","journal-title":"Toxicol Mech Methods"},{"issue":"4","key":"4112_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00210-019-01782-4","volume":"393","author":"KM Ibrahim","year":"2020","unstructured":"Ibrahim KM, Mantawy EM, Elanany MM, Abdelgawad HS, Khalifa NM, Hussien RH, El-Demerdash E (2020) Protection from doxorubicin-induced nephrotoxicity by clindamycin: novel antioxidant, anti-inflammatory and anti-apoptotic roles. Naunyn Schmiedebergs Arch Pharmacol 393(4):739\u2013748","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"12","key":"4112_CR61","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1007\/s11064-021-03428-5","volume":"46","author":"G Ibrahim Fouad","year":"2021","unstructured":"Ibrahim Fouad G, Ahmed KA (2021) Neuroprotective potential of berberine against doxorubicin-induced toxicity in rat\u2019s brain. Neurochem Res 46(12):3247\u20133263","journal-title":"Neurochem Res"},{"issue":"2","key":"4112_CR62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12012-021-09710-w","volume":"22","author":"G Ibrahim Fouad","year":"2022","unstructured":"Ibrahim Fouad G, Ahmed KA (2022) Curcumin ameliorates doxorubicin-induced cardiotoxicity and hepatotoxicity via suppressing oxidative stress and modulating iNOS, NF-kappaB, and TNF-alpha in rats. Cardiovasc Toxicol 22(2):152\u2013166","journal-title":"Cardiovasc Toxicol"},{"issue":"3","key":"4112_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22962","volume":"36","author":"IO Imosemi","year":"2022","unstructured":"Imosemi IO, Owumi SE, Arunsi UO (2022) Biochemical and histological alterations of doxorubicin-induced neurotoxicity in rats: Protective role of luteolin. J Biochem Mol Toxicol 36(3):e22962","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"4112_CR64","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1200\/JCO.1985.3.6.818","volume":"3","author":"KK Jain","year":"1985","unstructured":"Jain KK, Casper ES, Geller NL, Hakes TB, Kaufman RJ, Currie V et al (1985) A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer. J Clin Oncol 3(6):818\u2013826","journal-title":"J Clin Oncol"},{"issue":"5","key":"4112_CR65","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0936-6555(05)80269-9","volume":"6","author":"ND James","year":"1994","unstructured":"James ND, Coker RJ, Tomlinson D, Harris JR, Gompels M, Pinching AJ, Stewart JS (1994) Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi\u2019s sarcoma in AIDS. Clin Oncol 6(5):294\u2013296","journal-title":"Clin Oncol"},{"issue":"21","key":"4112_CR66","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1158\/1078-0432.CCR-23-1055","volume":"29","author":"P Jeyabal","year":"2023","unstructured":"Jeyabal P, Bhagat A, Wang F, Roth M, Livingston JA, Gilchrist SC, Kleinerman ES (2023) Circulating microRNAs and cytokines as prognostic biomarkers for doxorubicin-induced cardiac injury and for evaluating the effectiveness of an exercise intervention. Clin Cancer Res 29(21):4430\u20134440","journal-title":"Clin Cancer Res"},{"issue":"50","key":"4112_CR67","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.1038\/onc.2010.379","volume":"29","author":"C Ji","year":"2010","unstructured":"Ji C, Yang B, Yang YL, He SH, Miao DS, He L, Bi ZG (2010) Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Oncogene 29(50):6557\u20136568","journal-title":"Oncogene"},{"key":"4112_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yjmcc.2020.02.009","volume":"140","author":"X Ji","year":"2020","unstructured":"Ji X, Ding W, Xu T, Zheng X, Zhang J, Liu M, Wang J (2020) MicroRNA-31-5p attenuates doxorubicin-induced cardiotoxicity via quaking and circular RNA Pan3. J Mol Cell Cardiol 140:56\u201367","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"4112_CR69","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1159\/000491896","volume":"48","author":"X Jing","year":"2018","unstructured":"Jing X, Yang J, Jiang L, Chen J, Wang H (2018) MicroRNA-29b regulates the mitochondria-dependent apoptotic pathway by targeting bax in doxorubicin cardiotoxicity. Cell Physiol Biochem 48(2):692\u2013704","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"4112_CR70","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/molecules22101589","volume":"22","author":"R Johnson","year":"2017","unstructured":"Johnson R, Shabalala S, Louw J, Kappo AP, Muller CJF (2017) Aspalathin reverts doxorubicin-induced cardiotoxicity through increased autophagy and decreased expression of p53\/mTOR\/p62 signaling. Molecules 22(10):1589","journal-title":"Molecules"},{"issue":"8","key":"4112_CR71","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jiac.2018.03.010","volume":"24","author":"AM Kabel","year":"2018","unstructured":"Kabel AM, Alzahrani AA, Bawazir NM, Khawtani RO, Arab HH (2018) Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-beta1\/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity. J Infect Chemother 24(8):623\u2013631","journal-title":"J Infect Chemother"},{"issue":"1","key":"4112_CR72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tox.2004.12.003","volume":"209","author":"Y Kalender","year":"2005","unstructured":"Kalender Y, Yel M, Kalender S (2005) Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology 209(1):39\u201345","journal-title":"Toxicology"},{"issue":"3","key":"4112_CR73","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3892\/ol.2016.4175","volume":"11","author":"M Kawano","year":"2016","unstructured":"Kawano M, Tanaka K, Itonaga I, Iwasaki T, Miyazaki M, Ikeda S, Tsumura H (2016) Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma. Oncol Lett 11(3):2169\u20132175","journal-title":"Oncol Lett"},{"key":"4112_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2021.04.003","volume":"85","author":"YA Khadrawy","year":"2021","unstructured":"Khadrawy YA, Hosny EN, Mohammed HS (2021) Protective effect of nanocurcumin against neurotoxicity induced by doxorubicin in rat\u2019s brain. Neurotoxicology 85:1\u20139","journal-title":"Neurotoxicology"},{"key":"4112_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.toxlet.2018.02.024","volume":"288","author":"SR Khalil","year":"2018","unstructured":"Khalil SR, Mohammed AT, Abd El-Fattah AH, Zaglool AW (2018) Intermediate filament protein expression pattern and inflammatory response changes in kidneys of rats receiving doxorubicin chemotherapy and quercetin. Toxicol Lett 288:89\u201398","journal-title":"Toxicol Lett"},{"issue":"6","key":"4112_CR76","first-page":"2467","volume":"61","author":"K Kiyomiya","year":"2001","unstructured":"Kiyomiya K, Matsuo S, Kurebe M (2001) Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex. Cancer Res 61(6):2467\u20132471","journal-title":"Cancer Res"},{"issue":"1","key":"4112_CR77","doi-asserted-by":"publisher","first-page":"1344077","DOI":"10.1080\/16546628.2017.1344077","volume":"61","author":"A Korga","year":"2017","unstructured":"Korga A, Jozefczyk A, Zgorka G, Homa M, Ostrowska M, Burdan F, Dudka J (2017) Evaluation of the phytochemical composition and protective activities of methanolic extracts of Centaurea borysthenica and Centaurea daghestanica (Lipsky) Wagenitz on cardiomyocytes treated with doxorubicin. Food Nutr Res 61(1):1344077","journal-title":"Food Nutr Res"},{"issue":"6","key":"4112_CR78","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/cncr.22904","volume":"110","author":"V Launay-Vacher","year":"2007","unstructured":"Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O (2007) Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 110(6):1376\u20131384","journal-title":"Cancer"},{"issue":"9","key":"4112_CR79","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/1097-0142(19800501)45:9<2231::AID-CNCR2820450902>3.0.CO;2-3","volume":"45","author":"YT Lee","year":"1980","unstructured":"Lee YT, Chan KK, Harris PA, Cohen JL (1980) Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration. Cancer 45(9):2231\u20132239","journal-title":"Cancer"},{"issue":"2","key":"4112_CR80","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","volume":"32","author":"EA Lefrak","year":"1973","unstructured":"Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA (1973) A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32(2):302\u2013314","journal-title":"Cancer"},{"key":"4112_CR81","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev.nu.12.070192.002021","volume":"12","author":"EA Leibold","year":"1992","unstructured":"Leibold EA, Guo B (1992) Iron-dependent regulation of ferritin and transferrin receptor expression by the iron-responsive element binding protein. Annu Rev Nutr 12:345\u2013368","journal-title":"Annu Rev Nutr"},{"key":"4112_CR82","volume":"26","author":"XQ Li","year":"2020","unstructured":"Li XQ, Liu YK, Yi J, Dong JS, Zhang PP, Wan L, Li K (2020) MicroRNA-143 increases oxidative stress and myocardial cell apoptosis in a mouse model of doxorubicin-induced cardiac toxicity. Med Sci Monit 26:e920394","journal-title":"Med Sci Monit"},{"key":"4112_CR83","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3892\/ijmm.2021.4958","volume":"48","author":"Z Li","year":"2021","unstructured":"Li Z, Ye Z, Ma J, Gu Q, Teng J, Gong X (2021) MicroRNA-133b alleviates doxorubicin-induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2. Int J Mol Med 48:125","journal-title":"Int J Mol Med"},{"key":"4112_CR84","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/DDDT.S151511","volume":"12","author":"D Liao","year":"2018","unstructured":"Liao D, Guo Y, Xiang D, Dang R, Xu P, Cai H, Jiang P (2018) Dysregulation of Neuregulin-1\/ErbB signaling in the hippocampus of rats after administration of doxorubicin. Drug des Devel Ther 12:231\u2013239","journal-title":"Drug des Devel Ther"},{"issue":"5","key":"4112_CR85","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00213-023-06357-z","volume":"240","author":"D Liao","year":"2023","unstructured":"Liao D, Shangguan D, Wu Y, Chen Y, Liu N, Tang J, Shi Y (2023) Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways. Psychopharmacology 240(5):1179\u20131190","journal-title":"Psychopharmacology"},{"issue":"11","key":"4112_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22011","volume":"9","author":"Z Lin","year":"2023","unstructured":"Lin Z, Wang J (2023) Taxifolin protects against doxorubicin-induced cardiotoxicity and ferroptosis by adjusting microRNA-200a-mediated Nrf2 signaling pathway. Heliyon 9(11):e22011","journal-title":"Heliyon"},{"issue":"10","key":"4112_CR87","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.008220","volume":"14","author":"H Lin","year":"2021","unstructured":"Lin H, Meng L, Sun Z, Sun S, Huang X, Lin N, Guo H (2021) Yellow wine polyphenolic compound protects against doxorubicin-induced cardiotoxicity by modulating the composition and metabolic function of the gut microbiota. Circ Heart Fail 14(10):e008220","journal-title":"Circ Heart Fail"},{"issue":"2","key":"4112_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22639","volume":"35","author":"X Liu","year":"2021","unstructured":"Liu X, Qiu Y, Liu Y, Huang N, Hua C, Wang Q, Yin Y (2021) Citronellal ameliorates doxorubicin-induced hepatotoxicity via antioxidative stress, antiapoptosis, and proangiogenesis in rats. J Biochem Mol Toxicol 35(2):e22639","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"4112_CR89","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/ph16060797","volume":"16","author":"P Liu","year":"2023","unstructured":"Liu P, Wu J, Yu X, Guo L, Zhao L, Ban T, Huang Y (2023a) Metabolomics and network analyses reveal phenylalanine and tyrosine as signatures of anthracycline-induced hepatotoxicity. Pharmaceuticals (Basel) 16(6):797","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"4112_CR90","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00726-022-03231-8","volume":"55","author":"P Liu","year":"2023","unstructured":"Liu P, Guo L, Yu X, Liu P, Yu Y, Kong X, Huang Y (2023b) Identification of region-specific amino acid signatures for doxorubicin-induced chemo brain. Amino Acids 55(3):325\u2013336","journal-title":"Amino Acids"},{"issue":"19","key":"4112_CR91","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3390\/nu14194017","volume":"14","author":"G Lu","year":"2022","unstructured":"Lu G, Liu Q, Gao T, Li J, Zhang J, Chen O, Gu J (2022) Resveratrol and FGF1 synergistically ameliorates doxorubicin-induced cardiotoxicity via activation of SIRT1-NRF2 pathway. Nutrients 14(19):2022","journal-title":"Nutrients"},{"key":"4112_CR92","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2147\/IJN.S382109","volume":"18","author":"W Lu","year":"2023","unstructured":"Lu W, Liu W, Hu A, Shen J, Yi H, Cheng Z (2023) Combinatorial polydopamine-liposome nanoformulation as an effective anti-breast cancer therapy. Int J Nanomedicine 18:861\u2013879","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"4112_CR93","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.bbadis.2016.12.021","volume":"1863","author":"Y Ma","year":"2017","unstructured":"Ma Y, Yang L, Ma J, Lu L, Wang X, Ren J, Yang J (2017) Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis. Biochim Biophys Acta Mol Basis Dis 1863(8):1904\u20131911","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"12","key":"4112_CR94","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/1873-3468.14091","volume":"595","author":"ZH Maayah","year":"2021","unstructured":"Maayah ZH, Alam AS, Takahara S, Soni S, Ferdaoussi M, Matsumura N, Dyck JRB (2021) Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice. FEBS Lett 595(12):1681\u20131695","journal-title":"FEBS Lett"},{"issue":"2","key":"4112_CR95","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1474-9726.2007.00358.x","volume":"7","author":"Y Maejima","year":"2008","unstructured":"Maejima Y, Adachi S, Ito H, Hirao K, Isobe M (2008) Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage. Aging Cell 7(2):125\u2013136","journal-title":"Aging Cell"},{"key":"4112_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2024.102330","volume":"87","author":"SM Manawy","year":"2024","unstructured":"Manawy SM, Faruk EM, Hindawy RF, Hassan MM, Farrag DMG, Bashar MAE, Kamal KM (2024) Modulation of the Sirtuin-1 signaling pathway in doxorubicin-induced nephrotoxicity (synergistic amelioration by resveratrol and pirfenidone). Tissue Cell 87:102330","journal-title":"Tissue Cell"},{"issue":"7","key":"4112_CR97","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/jcmm.17230","volume":"26","author":"J Meng","year":"2022","unstructured":"Meng J, Xu C (2022) MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT. J Cell Mol Med 26(7):2076\u20132088","journal-title":"J Cell Mol Med"},{"key":"4112_CR98","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/molecules29051155","volume":"29","author":"AA Metwally","year":"2024","unstructured":"Metwally AA, Ganguly S, Biomi N, Yao M, Elbayoumi T (2024) Cationic vitamin E-TPGS mixed micelles of berberine to neutralize doxorubicin-induced cardiotoxicity via amelioration of mitochondrial dysfunction and impeding apoptosis. Molecules 29:1155","journal-title":"Molecules"},{"issue":"7","key":"4112_CR99","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1096\/fasebj.12.7.541","volume":"12","author":"G Minotti","year":"1998","unstructured":"Minotti G, Recalcati S, Mordente A, Liberi G, Calafiore AM, Mancuso C, Cairo G (1998) The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase\/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J 12(7):541\u2013552","journal-title":"FASEB J"},{"issue":"2","key":"4112_CR100","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1096\/fasebj.13.2.199","volume":"13","author":"G Minotti","year":"1999","unstructured":"Minotti G, Cairo G, Monti E (1999) Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J 13(2):199\u2013212","journal-title":"FASEB J"},{"issue":"12","key":"4112_CR101","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1139\/cjpp-2018-0259","volume":"96","author":"EA Mohamed","year":"2018","unstructured":"Mohamed EA, Ahmed HI, Zaky HS (2018) Protective effect of irbesartan against doxorubicin-induced nephrotoxicity in rats: implication of AMPK, PI3K\/Akt, and mTOR signaling pathways. Can J Physiol Pharmacol 96(12):1209\u20131217","journal-title":"Can J Physiol Pharmacol"},{"issue":"6","key":"4112_CR102","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00280-004-0825-y","volume":"54","author":"K Mross","year":"2004","unstructured":"Mross K, Niemann B, Massing U, Drevs J, Unger C, Bhamra R, Swenson CE (2004) Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study. Cancer Chemother Pharmacol 54(6):514\u2013524","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"4112_CR103","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","volume":"15","author":"FM Muggia","year":"1997","unstructured":"Muggia FM, Hainsworth JD, Jeffers S, Miller P, Groshen S, Tan M, Liang LJ (1997) Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol 15(3):987\u2013993","journal-title":"J Clin Oncol"},{"issue":"1","key":"4112_CR104","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/CAD.0000000000000299","volume":"27","author":"K Nagai","year":"2016","unstructured":"Nagai K, Fukuno S, Oda A, Konishi H (2016) Protective effects of taurine on doxorubicin-induced acute hepatotoxicity through suppression of oxidative stress and apoptotic responses. Anticancer Drugs 27(1):17\u201323","journal-title":"Anticancer Drugs"},{"key":"4112_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114818","volume":"378","author":"BL Nguyen","year":"2024","unstructured":"Nguyen BL, Baumfalk DR, Lapierre-Nguyen SS, Zhong R, Doerr V, Montalvo RN, Smuder AJ (2024) Effects of exercise and doxorubicin on acute diaphragm neuromuscular transmission failure. Exp Neurol 378:114818","journal-title":"Exp Neurol"},{"issue":"5","key":"4112_CR106","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s11064-021-03522-8","volume":"47","author":"N Okudan","year":"2022","unstructured":"Okudan N, Belviranli M, Sezer T (2022) Potential protective effect of coenzyme Q10 on doxorubicin-induced neurotoxicity and behavioral disturbances in rats. Neurochem Res 47(5):1280\u20131289","journal-title":"Neurochem Res"},{"issue":"12","key":"4112_CR107","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/ph14121305","volume":"14","author":"MAA Orabi","year":"2021","unstructured":"Orabi MAA, Khalil HMA, Abouelela ME, Zaafar D, Ahmed YH, Naggar RA, Hamdan DI (2021) Carissa macrocarpa leaves polar fraction ameliorates doxorubicin-induced neurotoxicity in rats via downregulating the oxidative stress and inflammatory markers. Pharmaceuticals (Basel) 14(12):1305","journal-title":"Pharmaceuticals (Basel)"},{"key":"4112_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2021.103624","volume":"85","author":"Y Pan","year":"2021","unstructured":"Pan Y, Pan YM, Liu FT, Xu SL, Gu JT, Hang PZ, Du ZM (2021) MicroRNA-98 ameliorates doxorubicin-induced cardiotoxicity via regulating caspase-8 dependent Fas\/RIP3 pathway. Environ Toxicol Pharmacol 85:103624","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"4112_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23559","volume":"38","author":"D Patel","year":"2024","unstructured":"Patel D, Yadav P, Singh SK, Tanwar SS, Sehrawat A, Khurana A, Navik U (2024) Betaine alleviates doxorubicin-induced nephrotoxicity by preventing oxidative insults, inflammation, and fibrosis through the modulation of Nrf2\/HO-1\/NLRP3 and TGF-beta expression. J Biochem Mol Toxicol 38(1):e23559","journal-title":"J Biochem Mol Toxicol"},{"issue":"5","key":"4112_CR110","first-page":"2020","volume":"9","author":"G Pepe","year":"2020","unstructured":"Pepe G, Salviati E, Rapa SF, Ostacolo C, Cascioferro S, Manfra M, Campiglia P (2020) Citrus sinensis and Vitis vinifera Protect Cardiomyocytes from Doxorubicin-Induced Oxidative Stress: Evaluation of Onconutraceutical Potential of Vegetable Smoothies. Antioxidants (Basel). 9(5):2020","journal-title":"Antioxidants (Basel)."},{"issue":"4","key":"4112_CR111","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.livres.2021.04.002","volume":"5","author":"SR Pondugula","year":"2021","unstructured":"Pondugula SR, Salamat JM, Abbott KL, Flannery PC, Majrashi M, Almaghrabi M, Dhanasekaran M (2021) A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL\/6J mice. Liver Res 5(4):239\u2013242","journal-title":"Liver Res"},{"issue":"22","key":"4112_CR112","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/molecules25225259","volume":"25","author":"RM Pop","year":"2020","unstructured":"Pop RM, Bocsan IC, Buzoianu AD, Chedea VS, Socaci SA, Pecoraro M, Popolo A (2020) Evaluation of the antioxidant activity of Nigella sativa L. and Allium ursinum extracts in a cellular model of doxorubicin-induced cardiotoxicity. Molecules 25(22):2020","journal-title":"Molecules"},{"issue":"1","key":"4112_CR113","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.arcmed.2019.12.004","volume":"51","author":"Z Rafiee","year":"2020","unstructured":"Rafiee Z, Moaiedi MZ, Gorji AV, Mansouri E (2020) P-coumaric acid mitigates doxorubicin-induced nephrotoxicity through suppression of oxidative stress, inflammation and apoptosis. Arch Med Res 51(1):32\u201340","journal-title":"Arch Med Res"},{"issue":"10","key":"4112_CR114","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2174\/1386207325666220617113744","volume":"25","author":"S Rawal","year":"2022","unstructured":"Rawal S, Gupta P, Bhatnagar P, Yadav HN, Dinda AK (2022) Solid lipid nanoformulation of berberine attenuates doxorubicin triggered in vitro inflammation in H9c2 rat cardiomyocytes. Comb Chem High Throughput Screen 25(10):1695\u20131706","journal-title":"Comb Chem High Throughput Screen"},{"issue":"6","key":"4112_CR115","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1055\/s-0035-1569447","volume":"66","author":"K Razavi-Azarkhiavi","year":"2016","unstructured":"Razavi-Azarkhiavi K, Jafarian AH, Abnous K, Razavi BM, Shirani K, Zeinali M, Karimi G (2016) The comparison of biodistribution, efficacy and toxicity of two pegylated liposomal doxorubicin formulations in mice bearing C-26 colon carcinoma: a preclinical study. Drug Res (Stuttg) 66(6):330\u2013336","journal-title":"Drug Res (Stuttg)"},{"issue":"4","key":"4112_CR116","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/0973-1482.139267","volume":"10","author":"S Rivankar","year":"2014","unstructured":"Rivankar S (2014) An overview of doxorubicin formulations in cancer therapy. J Cancer Res Ther 10(4):853\u2013858","journal-title":"J Cancer Res Ther"},{"key":"4112_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.110628","volume":"187","author":"S Saad","year":"2020","unstructured":"Saad S, Ahmad I, Kawish SM, Khan UA, Ahmad FJ, Ali A, Jain GK (2020) Improved cardioprotective effects of hesperidin solid lipid nanoparticles prepared by supercritical antisolvent technology. Colloids Surf B Biointerfaces 187:110628","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4112_CR118","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.fct.2019.01.034","volume":"125","author":"R Sahu","year":"2019","unstructured":"Sahu R, Dua TK, Das S, De Feo V, Dewanjee S (2019) Wheat phenolics suppress doxorubicin-induced cardiotoxicity via inhibition of oxidative stress, MAP kinase activation, NF-kappaB pathway, PI3K\/Akt\/mTOR impairment, and cardiac apoptosis. Food Chem Toxicol 125:503\u2013519","journal-title":"Food Chem Toxicol"},{"key":"4112_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.111045","volume":"135","author":"HA Sahyon","year":"2020","unstructured":"Sahyon HA, Al-Harbi SA (2020) Chemoprotective role of an extract of the heart of the Phoenix dactylifera tree on adriamycin-induced cardiotoxicity and nephrotoxicity by regulating apoptosis, oxidative stress and PD-1 suppression. Food Chem Toxicol 135:111045","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"4112_CR120","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.3390\/antiox11101955","volume":"11","author":"R Sanchez-Sanchez","year":"2022","unstructured":"Sanchez-Sanchez R, Reinal I, Peiro-Molina E, Buigues M, Tejedor S, Hernandiz A, Sepulveda P (2022) MicroRNA-4732\u20133p is dysregulated in breast cancer patients with cardiotoxicity, and its therapeutic delivery protects the heart from doxorubicin-induced oxidative stress in rats. Antioxidants (Basel) 11(10):1955","journal-title":"Antioxidants (Basel)"},{"key":"4112_CR121","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mito.2019.05.008","volume":"47","author":"E Santos-Alves","year":"2019","unstructured":"Santos-Alves E, Rizo-Roca D, Marques-Aleixo I, Coxito P, Martins S, Guimaraes JT, Ascensao A (2019) Physical exercise positively modulates DOX-induced hepatic oxidative stress, mitochondrial dysfunction and quality control signaling. Mitochondrion 47:103\u2013113","journal-title":"Mitochondrion"},{"issue":"4","key":"4112_CR122","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/15376516.2023.2291123","volume":"34","author":"M Savran","year":"2024","unstructured":"Savran M, Asci S, Gulle K, Aslankoc R, Asci H, Karakuyu NF, Kaynak M (2024) Agomelatine ameliorates doxorubicin-induced cortical and hippocampal brain injury via inhibition of TNF-alpha\/NF-kB pathway. Toxicol Mech Methods 34(4):359\u2013368","journal-title":"Toxicol Mech Methods"},{"issue":"1","key":"4112_CR123","doi-asserted-by":"publisher","first-page":"14720","DOI":"10.1038\/s41598-020-71827-9","volume":"10","author":"S Sergazy","year":"2020","unstructured":"Sergazy S, Shulgau Z, Fedotovskikh G, Chulenbayeva L, Nurgozhina A, Nurgaziyev M, Aljofan M (2020) Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity. Sci Rep 10(1):14720","journal-title":"Sci Rep"},{"key":"4112_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.213147","volume":"142","author":"NG Shetake","year":"2022","unstructured":"Shetake NG, Ali M, Kumar A, Bellare J, Pandey BN (2022) Theranostic magnetic nanoparticles enhance DNA damage and mitigate doxorubicin-induced cardio-toxicity for effective multi-modal tumor therapy. Biomater Adv 142:213147","journal-title":"Biomater Adv"},{"issue":"8","key":"4112_CR125","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1113\/jphysiol.2014.270101","volume":"593","author":"TK Sin","year":"2015","unstructured":"Sin TK, Tam BT, Yung BY, Yip SP, Chan LW, Wong CS, Siu PM (2015) Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis. J Physiol 593(8):1887\u20131899","journal-title":"J Physiol"},{"key":"4112_CR126","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphar.2019.01030","volume":"10","author":"S Song","year":"2019","unstructured":"Song S, Chu L, Liang H, Chen J, Liang J, Huang Z, Chen X (2019) Protective effects of dioscin against doxorubicin-induced hepatotoxicity via regulation of Sirt1\/FOXO1\/NF-kappab signal. Front Pharmacol 10:1030","journal-title":"Front Pharmacol"},{"issue":"12","key":"4112_CR127","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1200\/JCO.2001.19.12.3117","volume":"19","author":"JA Sparano","year":"2001","unstructured":"Sparano JA, Malik U, Rajdev L, Sarta C, Hopkins U, Wolff AC (2001) Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer. J Clin Oncol 19(12):3117\u20133125","journal-title":"J Clin Oncol"},{"issue":"6","key":"4112_CR128","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/clpt.1987.92","volume":"41","author":"PA Speth","year":"1987","unstructured":"Speth PA, Linssen PC, Holdrinet RS, Haanen C (1987) Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion. Clin Pharmacol Ther 41(6):661\u2013665","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"4112_CR129","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.1002\/jcp.26854","volume":"233","author":"H Sun","year":"2018","unstructured":"Sun H, Tong Z, Fang Y, Jiang B, Liang P, Tang Y, Xiao X (2018) Nucleolin protects against doxorubicin-induced cardiotoxicity via upregulating microRNA-21. J Cell Physiol 233(12):9516\u20139525","journal-title":"J Cell Physiol"},{"issue":"1","key":"4112_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202200450","volume":"20","author":"X Sun","year":"2023","unstructured":"Sun X, Zhou L, Han Y, Yang Q, Li X, Xin B, Guo C (2023) Scutellarin attenuates doxorubicin-induced cardiotoxicity by inhibiting myocardial fibrosis, apoptosis and autophagy in rats. Chem Biodivers 20(1):e202200450","journal-title":"Chem Biodivers"},{"issue":"8","key":"4112_CR131","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2174\/1567201818666210202105531","volume":"18","author":"R Tabbasam","year":"2021","unstructured":"Tabbasam R, Khursid S, Ishaq Y, Malik A (2021) In vivo evaluation of inorganic nanoparticle complexes against CCL4 induced hepatotoxicity. Curr Drug Deliv 18(8):1197\u20131203","journal-title":"Curr Drug Deliv"},{"key":"4112_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.624706","volume":"12","author":"K Tene","year":"2021","unstructured":"Tene K, Kalyan Kumar M, Basveshwar G, Eswara Rao P, Jagadeesh Kumar G, Kumar P, Naidu VGM (2021) Polyphenolic-rich compounds from Dillenia pentagyna (Roxb.) attenuates the doxorubicin-induced cardiotoxicity: a high-frequency ultrasonography assisted approach. Front Pharmacol 12:624706","journal-title":"Front Pharmacol"},{"issue":"7","key":"4112_CR133","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","volume":"21","author":"CF Thorn","year":"2011","unstructured":"Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB (2011) Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics 21(7):440\u2013446","journal-title":"Pharmacogenet Genomics"},{"issue":"7","key":"4112_CR134","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/0748233713483203","volume":"31","author":"F Tulubas","year":"2015","unstructured":"Tulubas F, Gurel A, Oran M, Topcu B, Caglar V, Uygur E (2015) The protective effects of omega-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats. Toxicol Ind Health 31(7):638\u2013644","journal-title":"Toxicol Ind Health"},{"issue":"5","key":"4112_CR135","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91(5):710\u2013717","journal-title":"Ann Intern Med"},{"issue":"4","key":"4112_CR136","first-page":"550","volume":"9","author":"AF Wali","year":"2020","unstructured":"Wali AF, Rashid S, Rashid SM, Ansari MA, Khan MR, Haq N, Rehman MU (2020) Naringenin regulates doxorubicin-induced liver dysfunction: impact on oxidative stress and inflammation. Plants (Basel) 9(4):550","journal-title":"Plants (Basel)"},{"key":"4112_CR137","doi-asserted-by":"publisher","first-page":"7395239","DOI":"10.1155\/2019\/7395239","volume":"2019","author":"Y Wang","year":"2019","unstructured":"Wang Y, Chao X, Ahmad FUD, Shi H, Mehboob H, Hassan W (2019) Phoenix dactylifera protects against doxorubicin-induced cardiotoxicity and nephrotoxicity. Cardiol Res Pract 2019:7395239","journal-title":"Cardiol Res Pract"},{"issue":"1","key":"4112_CR138","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1186\/s12951-024-03069-0","volume":"22","author":"K Wang","year":"2024","unstructured":"Wang K, Geng S, Wang F, Fang B, Qian H, Li Y, Yu Z (2024) Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy. J Nanobiotechnology 22(1):793","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"4112_CR139","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/cncr.20272","volume":"100","author":"JS Wefel","year":"2004","unstructured":"Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100(11):2292\u20132299","journal-title":"Cancer"},{"issue":"4","key":"4112_CR140","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/nu8040243","volume":"8","author":"YQ Wu","year":"2016","unstructured":"Wu YQ, Dang RL, Tang MM, Cai HL, Li HD, Liao DH, Jiang P (2016) Long chain omega-3 polyunsaturated fatty acid supplementation alleviates doxorubicin-induced depressive-like behaviors and neurotoxicity in rats: involvement of oxidative stress and neuroinflammation. Nutrients 8(4):243","journal-title":"Nutrients"},{"key":"4112_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114087","volume":"157","author":"Q Wu","year":"2023","unstructured":"Wu Q, Chen J, Zheng X, Song J, Yin L, Guo H, Yang Q (2023) Kaempferol attenuates doxorubicin-induced renal tubular injury by inhibiting ROS\/ASK1-mediated activation of the MAPK signaling pathway. Biomed Pharmacother 157:114087","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4112_CR142","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00280-008-0744-4","volume":"63","author":"P Xiang","year":"2009","unstructured":"Xiang P, Deng HY, Li K, Huang GY, Chen Y, Tu L, Sung RY (2009) Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol 63(2):343\u2013349","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4112_CR143","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jphs.2020.10.002","volume":"145","author":"C Xiang","year":"2021","unstructured":"Xiang C, Yan Y, Zhang D (2021) Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro. J Pharmacol Sci 145(1):6\u201315","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"4112_CR144","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15376516.2023.2268717","volume":"34","author":"T Yalcin","year":"2024","unstructured":"Yalcin T, Kaya S, Kuloglu T (2024) Resveratrol may dose-dependently modulate nephrin and OTULIN levels in a doxorubicin-induced nephrotoxicity model. Toxicol Mech Methods 34(1):98\u2013108","journal-title":"Toxicol Mech Methods"},{"key":"4112_CR145","doi-asserted-by":"publisher","first-page":"5184135","DOI":"10.1155\/2022\/5184135","volume":"2022","author":"M Yan","year":"2022","unstructured":"Yan M, Cao Y, Wang Q, Xu K, Dou L, Huang X, Li J (2022) miR-488-3p protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting CyclinG1. Oxid Med Cell Longev 2022:5184135","journal-title":"Oxid Med Cell Longev"},{"key":"4112_CR146","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166306","author":"Z Yao","year":"2023","unstructured":"Yao Z, Dong H, Zhu J, Du L, Luo Y, Liu Q, Zhang H (2023) Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.166306","journal-title":"JCI Insight"},{"key":"4112_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110111","volume":"365","author":"EN Yesilkent","year":"2022","unstructured":"Yesilkent EN, Ceylan H (2022) Investigation of the multi-targeted protection potential of tannic acid against doxorubicin-induced kidney damage in rats. Chem Biol Interact 365:110111","journal-title":"Chem Biol Interact"},{"issue":"9","key":"4112_CR148","volume":"12","author":"I Youssef","year":"2020","unstructured":"Youssef I, Lee A, Kukunoor S, Taiwo E, Luhrs CA, Schreiber D (2020) Patterns of care and survival of metastatic metaplastic breast cancer patients. Cureus 12(9):e10339","journal-title":"Cureus"},{"key":"4112_CR149","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.biopha.2017.07.051","volume":"93","author":"J Zhang","year":"2017","unstructured":"Zhang J, Cui L, Han X, Zhang Y, Zhang X, Chu X, Chu L (2017) Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis. Biomed Pharmacother 93:1253\u20131260","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4112_CR150","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12951-022-01628-x","volume":"20","author":"B Zhang","year":"2022","unstructured":"Zhang B, Zhang Y, Dang W, Xing B, Yu C, Guo P, Liu Z (2022) The anti-tumor and renoprotection study of E-[c(RGDfK)(2)]\/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride\/salvianolic acid A. J Nanobiotechnology 20(1):425","journal-title":"J Nanobiotechnology"},{"key":"4112_CR151","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.redox.2018.02.026","volume":"16","author":"L Zhao","year":"2018","unstructured":"Zhao L, Tao X, Qi Y, Xu L, Yin L, Peng J (2018a) Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Redox Biol 16:189\u2013198","journal-title":"Redox Biol"},{"key":"4112_CR152","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","volume":"15","author":"L Zhao","year":"2018","unstructured":"Zhao L, Qi Y, Xu L, Tao X, Han X, Yin L, Peng J (2018b) MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biol 15:284\u2013296","journal-title":"Redox Biol"},{"key":"4112_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104276","volume":"146","author":"X Zhao","year":"2019","unstructured":"Zhao X, Jin Y, Li L, Xu L, Tang Z, Qi Y, Peng J (2019) MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1. Pharmacol Res 146:104276","journal-title":"Pharmacol Res"},{"key":"4112_CR154","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.freeradbiomed.2018.10.418","volume":"129","author":"X Zhou","year":"2018","unstructured":"Zhou X, Xu P, Dang R, Guo Y, Li G, Qiao Y, Jiang P (2018) The involvement of autophagic flux in the development and recovery of doxorubicin-induced neurotoxicity. Free Radic Biol Med 129:440\u2013445","journal-title":"Free Radic Biol Med"},{"key":"4112_CR155","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.lfs.2018.06.008","volume":"207","author":"AA Zidan","year":"2018","unstructured":"Zidan AA, El-Ashmawy NE, Khedr EG, Ebeid EM, Salem ML, Mosalam EM (2018) Loading of doxorubicin and thymoquinone with F2 gel nanofibers improves the antitumor activity and ameliorates doxorubicin-associated nephrotoxicity. Life Sci 207:461\u2013470","journal-title":"Life Sci"},{"key":"4112_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116448","volume":"465","author":"A Zidan","year":"2023","unstructured":"Zidan A, El Saadany AA, El Maghraby GM, Abdin AA, Hedya SE (2023) Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice. Toxicol Appl Pharmacol 465:116448","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"4112_CR157","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.taap.2009.09.012","volume":"242","author":"BN Zordoky","year":"2010","unstructured":"Zordoky BN, Anwar-Mohamed A, Aboutabl ME, El-Kadi AO (2010) Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicol Appl Pharmacol 242(1):38\u201346","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"4112_CR158","doi-asserted-by":"publisher","first-page":"13061","DOI":"10.3390\/molecules190913061","volume":"19","author":"Y Zu","year":"2014","unstructured":"Zu Y, Yang Z, Tang S, Han Y, Ma J (2014) Effects of P-glycoprotein and its inhibitors on apoptosis in K562 cells. Molecules 19(9):13061\u201313075","journal-title":"Molecules"},{"issue":"2","key":"4112_CR159","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0304-4165(86)90181-9","volume":"884","author":"JL Zweier","year":"1986","unstructured":"Zweier JL, Gianni L, Muindi J, Myers CE (1986) Differences in O2 reduction by the iron complexes of adriamycin and daunomycin: the importance of the sidechain hydroxyl group. Biochim Biophys Acta 884(2):326\u2013336","journal-title":"Biochim Biophys Acta"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04112-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04112-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04112-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:03:20Z","timestamp":1756911800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04112-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":159,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4112"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04112-1","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}